News
| Feb 03 | $PRGO I like it long at $92 on closing price by MomentumPartnersLLC |
| Feb 03 | Perrigo Earnings Preview |
| Feb 03 | HIGH $PUT VOLU $MIPS 6455% $FCFS 4573% $BEAV 3869% $CCOI 2985% $ZOLT 2712% $BBL 2608% $PRGO 2129% $ZNGA 2070% $MNKD 1697% $CCE 1359% by livevol_pro |
| Feb 03 | $PRGO interesting PUT volume today note earnings next tues b4 open by MomentumPartnersLLC |
| Feb 03 | Notable Put Options Activity in Perrigo Benzinga |
| Feb 03 | HIGH $PUT VOLU $MIPS 6455% $CCOI 2985% $BBL 2505% $ZOLT 2112% $PRGO 1649% $MNKD 1207% $CAR 1201% $DAN 910% $EW 874% $ZNGA 707% by livevol_pro |
| Feb 03 | Perrigo's Growth May Not Be What It Seems Fool |
| Feb 03 | Generic business cutthroat. Sell stop below the 40 weel at 91.70 $PRGO http://chart.ly/csvwytg by chartsmart |
| Feb 02 | $PRGO. Garltey Pattern formed. Look for Pivot to get long . 127% Exret 92.22, 61.8% Exret 92.96 and 100% APP at 92.15 by millchristian |
| Feb 02 | $PRGO looking for gap down on open with green candle tommorrow stalking long at 92 by MomentumPartnersLLC |
| Feb 02 | [video] Daily Dividend Report: UNP, V, LVS, AGN, PRGO |
| Feb 02 | Daily Dividend Report: UNP, V, LVS, AGN, PRGO |
Profile
Exchange: NASDAQGS Sector: Healthcare Industry: Drug Related Products
Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. The company's shares are traded on the NASDAQ and the Tel Aviv Stock Exchange; as a result of the merger with Agis Industries the company is a constituent of the TA-25 Index. The company was founded in 1887 and is headquartered in Allegan, Michigan.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Perrigo Company is up N/A over the last year vs S&P 500 Total Return up N/A, Impax Laboratories down N/A, and Cyanotech Corporation up N/A.
- PRGO Total Returns
- ^SPXTR Total Returns
- IPXL Total Returns
- CYAN Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these PRGO related companies
Pro Strategies Featuring PRGO
Did Perrigo Company make it into our Pro Portfolio Strategies?
PRGO Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other PRGO Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PRGO | 93.66 | 0.53 | 0.57% | 8.73B |
| LUV | 10.04 | 0.29 | 2.97% | 7.82B |
| EGO | 14.76 | -0.74 | -4.77% | 8.13B |
| TM | 76.47 | 0.24 | 0.31% | 119.89B |
| XLI | 37.26 | 0.63 | 1.72% | |
| GDX | 56.44 | -1.03 | -1.79% | |
| DV | 39.12 | 0.47 | 1.22% | 2.78B |
| BWLD | 70.30 | 1.52 | 2.21% | 1.29B |
| LOPE | 17.10 | 0.24 | 1.42% | 757.36M |
| RIG | 49.20 | 0.33 | 0.68% | 15.73B |
